FDA Import Refusal AEK-9195715-7/30002/1 — Novartis Pharma AG
The FDA refused shipment AEK-9195715-7/30002/1 from Novartis Pharma AG (Switzerland) on January 15, 2026. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- January 15, 2026
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 62GDY18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75